Nurse Led Aromatherapy
ConditionBurns and Scalds
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-7
SponsorKK Women's and Children's Hospital
About this trial
The goal of this trial is to see if aromatherapy in addition to pain medication, will help manage pain in pediatric burn patients during their first burn dressing change. Participants aged 2 months to 7 years old will be randomly assigned to usual care (pain medication only) or to receive aromatherapy in addition to pain medication prior to their first burn dressing change. The main question it aims to answer is:
-Does aromatherapy plus pain medication decrease pain more than pain medication alone for young children receiving their first burn dressing change?
All participants will receive the standard pain medications and have their pain assessed on medication administration (prior to aromatherapy for the intervention group), prior to dressing change (after aromatherapy for the intervention group), and 15 minutes after the dressing change is complete.
Once the final pain assessment is complete, there is no more information needed from participants for the purposes of the study. All participants will continue to follow up in the clinic for the remaining dressing changes as needed.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Seen in outpatient burn center
Burns not covering more than 7.5% of body surface area
First burn dressing change
Second degree burns
Disqualifiers
Allergy/hypersensitivity to essential oils, or any components of the aromatherapy formula
Airway/hypersensitivity to fragrances, paint fumes, or turpentine
Respiratory conditions (e.g. asthma, reactive airway disease, recent wheezing)
Inhalation injury
Trial design
Design model
Parallel
Treatments tested in this trial
Aromatherapy
Other interventionAromatherapy diffusion is a blend of three essential oils, bergamot mint, patchouli, and sweet orange.
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: Control Arm: Usual careNo intervention 0 interventions
Group B: Intervention ArmExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Pain score as measured by Face, Legs, Activity, Cry, and Consolability (FLACC) scale with first burn dressing change
Zero is equivalent to no pain and 10 indicates severe pain
Time frame
FLACC to be completed upon arrival in burn center (baseline), immediately prior to burn dressing change (preprocedural), and 15 minutes after burn dressing change is complete (postprocedural).Sponsors and contacts
Click on the lead sponsor to view all of their trials.
KK Women's and Children's Hospital
Lead sponsor
National Cancer Centre, Singapore
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: